TNF and rheumatoid arthritis: This is of potential interest as biomarkers of endothelial dysfunction-endothelial cell activation have been found elevated in patients with RA and anti-TNF-α therapy improved endothelial dysfunction [73, 74] and led to a reduction of the levels of some of these endothelial cell activation biomarkers [75].